Drug Profile, Expanded Targeted Panel by LC-MS/MS, Serum/Plasma
Use to detect drug exposure from among a targeted list of prescriptions, over-the-counter medications, and illicit drugs; for a complete list of drugs and drug metabolites detected, refer to Additional Technical Information. Not recommended to determine medication compliance or to assess for undisclosed drug/substance use in the context of pain management, substance use disorder treatment, or any other pharmacotherapies involving controlled substances.
New York DOH Approval Status
Plain red (no additives, serum gel or SST tubes are not acceptable), grey-top (NaF/oxalate), lavender (K2 or K3EDTA) or pink (K2EDTA).
Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 4 mL of serum or plasma into an ARUP Standard Transport Tube. (Min: 2 mL)
Gel Separator tubes or light blue (sodium citrate). Specimens exposed to repeated freeze/thaw cycles. Postmortem specimens.
After separation from cells: Ambient: 24 hours; Refrigerated: 2 weeks; Frozen: 2 months.
Qualitative Liquid Chromatography-Tandem Mass Spectrometry
The drug screen panel can detect 127 drugs and drug metabolites by LC-MS/MS. The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, or limitations of testing. The concentration at which the screening test can detect a drug or metabolite varies within a drug class. The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.
This assay is for medical purposes only; not valid for forensic use
For a complete list of drugs and drug metabolites detected, refer to the Additional Technical Information.
This test was developed, and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
If a specimen drug class is reported as positive, the test will report the confirmed component from the comprehensive drug class at no additional charge. (Classes include ARUP test codes 3005045, 3005046, 3005047, 3005048, 3005049, 3005050, 3005051, 3005052, 3005053, 3005054, 3005055, 3005056, 3005057, 3005058, or 3005059.)
80323; 80326; 80329; 80334; 80337; 80338; 80341; 80344; 80346; 80348; 80353; 80354; 80356; 80357; 80358; 80359; 80360; 80361; 80363; 80365; 80366; 80368; 80370; 80371; 80372; 80373; 80377; 83992 (Alt code: G0482)
|Component Test Code*||Component Chart Name||LOINC|
|3004842||Cough Suppressants, Serum/Plasma||3538-6|
|3004845||Muscle Relaxants, Serum/Plasma|
- Blood Screen
- Comprehensive drug screen
- Drug Analysis
- general toxicology
- Multiple Drug Analysis
- Tox Screen